HLX37
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLX37, covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors [EARLY_Phase 1]